Open AccessThrombolytic Refusal Over Telestroke
Author(s) -
Alicia Zha,
Adriana Rosero,
Rene M Malazarte,
Shima Bozorgui,
Christy Ankrom,
Liang Zhu,
Michele Joseph,
Alyssa Trevino,
Tiffany Cossey,
Sean I Savitz,
Tzu Ching Wu,
Amanda JagolinoCole
Publication year - 2021
Publication title -
neurology. clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.674
H-Index - 29
eISSN - 2163-0933
pISSN - 2163-0402
DOI - 10.1212/cpj.0000000000000975
Subject(s) - medicine , odds ratio , modified rankin scale , tissue plasminogen activator , stroke (engine) , confidence interval , emergency department , fibrinolytic agent , emergency medicine , ischemic stroke , mechanical engineering , engineering , ischemia , psychiatry
Tissue plasminogen activator (tPA) refusal is 4%-6% for acute ischemic stroke (AIS) in the emergency department. Telestroke (TS) has increased the use of tPA for AIS but is accompanied by barriers in communication that can affect tPA consent. We characterized the incidence of tPA refusal in our TS network and its associated reasons.